Levi Strauss (LEVI) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, LEVI broke through the 50-day moving average, which suggests a short-term bullish trend.The 50-day simple moving average is one of three major moving averages used by traders and analysts to determine support or resistance levels for a wide range of securities. But the 50-day is considered to be more important because it's the first marker of an up or down trend.Shares of LEVI have been moving higher over the past four weeks, up 6.4%. Plus, the company is currently a Zacks Rank #2 (Buy) stock, suggesting that LEVI could be poised for a continued surge.The bullish case solidifies once investors consider LEVI's positive earnings estimate revisions. No estimate has gone lower in the past two months for the current fiscal year, compared to 4 higher, while the consensus estimate has increased too.With a winning combination of earnings estimate revisions and hitting a key technical level, investors should keep their eye on LEVI for more gains in the near future. Breakout Biotech Stocks with Triple-Digit Profit Potential The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases. Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.See these 7 breakthrough stocks now>>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Levi Strauss & Co. (LEVI): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research